BillionToOne’s Pioneering Study Demonstrates 100% Accuracy for Non-Invasive Fetal RhD Detection in US Population

Peer reviewed research published in Green Journal shows BillionToOne’s NGS technology excels in testing diverse US populations MENLO PARK, Calif., Feb. 27, 2025 /PRNewswire/ — BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are…